FDA NDC Directory · JSON-LD · Markdown

Guaifenesin and Pseudoephedrine HCL

NDC 55111-798 · HUMAN OTC DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerDr. Reddys Laboratories Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA208369
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsGUAIFENESIN (600 mg/1)
PSEUDOEPHEDRINE HYDROCHLORIDE (60 mg/1)
Marketing started20171229
Package count5

External sources

Source: openFDA. Public-domain (CC0).